Century Bancorp Inc (CNBKA)

115.29  +0.07 (+0.06%)

After market: 115.29 0 (0%)

Fundamental Rating

1

CNBKA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 412 industry peers in the Banks industry. CNBKA has a bad profitability rating. Also its financial health evaluation is rather negative. CNBKA is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

CNBKA had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.63%
ROE 11.15%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CNBKA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 32.92%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for CNBKA remains at a similar level compared to 1 year ago.
CNBKA has a better debt/assets ratio than last year.

2.2 Solvency

CNBKA has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.73% over the past year.
Measured over the past years, CNBKA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.91% on average per year.
CNBKA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.90%.
Measured over the past years, CNBKA shows a small growth in Revenue. The Revenue has been growing by 7.92% on average per year.
EPS 1Y (TTM)8.73%
EPS 3Y12.21%
EPS 5Y12.91%
EPS growth Q2Q7.98%
Revenue 1Y (TTM)12.9%
Revenue growth 3Y7.2%
Revenue growth 5Y7.92%
Revenue growth Q2Q9.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CNBKA is valuated rather expensively with a Price/Earnings ratio of 19.18.
CNBKA's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.73.
Industry RankSector Rank
PE 19.18
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.49
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CNBKA has a yearly dividend return of 0.62%, which is pretty low.
With a Dividend Yield of 0.62, CNBKA pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 0.62%

5.2 History

The dividend of CNBKA has a limited annual growth rate of 4.00%.
CNBKA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

CNBKA pays out 1.65% of its income as dividend. This is a sustainable payout ratio.
The dividend of CNBKA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP1.65%
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Century Bancorp Inc

NASDAQ:CNBKA (11/12/2021, 7:51:50 PM)

After market: 115.29 0 (0%)

115.29

+0.07 (+0.06%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap860.39M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.62%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.18
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.49
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 11.15%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 32.92%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)8.73%
EPS 3Y12.21%
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.9%
Revenue growth 3Y7.2%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y